Loading organizations...
Loading organizations...
Biopharmaceutical company developing targeted protein degraders for cancer.
Biotheryx has raised $127.0M across 2 funding rounds.
Biotheryx has raised $127.0M in total across 2 funding rounds.
Biotheryx has raised $127.0M in total across 2 funding rounds.
Biotheryx's investors include Farallon Capital Management, Alexandria Venture Investments, Avidity Partners, Deep Track Capital, Irving Investors, Janus Henderson Investors, Lumira Ventures, Point72, Rock Springs Capital, Surveyor Capital, Tekla Capital Management, Wedbush Healthcare Partners.
Biotheryx has raised $127.0M across 2 funding rounds. Most recently, it raised $92.0M Series E in May 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 20, 2021 | $92.0M Series E | Farallon Capital Management | Alexandria Venture Investments, Avidity Partners, Deep Track Capital, Irving Investors, Janus Henderson Investors, Lumira Ventures, Point72, Rock Springs Capital, Surveyor Capital, Tekla Capital Management, Wedbush Healthcare Partners |
| Jul 28, 2020 | $35.0M Series D | Robert Platek |